gatifloxacin has been researched along with Drop Attack in 2 studies
Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Gatifloxacin is a synthetic broad-spectrum 8-methoxyfluoroquinolone approved by the United States Food and Drug Administration in December 1999." | 5.32 | Bradycardic syncope in 2 patients who recently began gatifloxacin treatment. ( Buxton, AE; Nicholson, WJ; Tammaro, D, 2003) |
| "Gatifloxacin is a synthetic broad-spectrum 8-methoxyfluoroquinolone approved by the United States Food and Drug Administration in December 1999." | 1.32 | Bradycardic syncope in 2 patients who recently began gatifloxacin treatment. ( Buxton, AE; Nicholson, WJ; Tammaro, D, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nicholson, WJ | 1 |
| Buxton, AE | 1 |
| Tammaro, D | 1 |
| Lannini, PB | 1 |
| Circiumaru, I | 1 |
2 other studies available for gatifloxacin and Drop Attack
| Article | Year |
|---|---|
Bradycardic syncope in 2 patients who recently began gatifloxacin treatment.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Bradycardia; Female; Fluoroquinolones; Gatifloxacin; | 2003 |
Gatifloxacin-induced QTc prolongation and ventricular tachycardia.
Topics: Aged; Anti-Infective Agents; Female; Fluoroquinolones; Gatifloxacin; Humans; Long QT Syndrome; Synco | 2001 |